Insider Transactions in Q2 2023 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2023
|
William Mariner Greenman Director |
SELL
Open market or private sale
|
Direct |
1,155
-4.66%
|
$26,565
$23.3 P/Share
|
|
May 26
2023
|
Ross Haghighat Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+2.58%
|
-
|
|
May 26
2023
|
Srinivas Akkaraju Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+50.0%
|
-
|
|
May 26
2023
|
William Mariner Greenman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+11.74%
|
-
|
|
May 26
2023
|
Dolca Thomas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+19.88%
|
-
|
|
May 26
2023
|
Davis Jerel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+0.45%
|
-
|
|
May 26
2023
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,300
+50.0%
|
-
|
|
Apr 24
2023
|
Eric Dobmeier President, CEO |
BUY
Open market or private sale
|
Direct |
1,200
+0.4%
|
$26,400
$22.26 P/Share
|
|
Apr 24
2023
|
Eric Dobmeier President, CEO |
SELL
Open market or private sale
|
Direct |
23,800
-7.3%
|
$499,800
$21.58 P/Share
|
|
Apr 24
2023
|
Eric Dobmeier President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.12%
|
$0
$0.42 P/Share
|
|
Apr 17
2023
|
Davis Jerel Director |
SELL
Open market or private sale
|
Direct |
295,808
-40.0%
|
$5,916,160
$20.75 P/Share
|
|
Apr 04
2023
|
Mahesh Krishnan Director |
SELL
Open market or private sale
|
Direct |
924
-42.02%
|
$21,252
$23.01 P/Share
|
|
Apr 03
2023
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-22.74%
|
$115,000
$23.34 P/Share
|
|
Apr 03
2023
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+10.21%
|
$0
$0.35 P/Share
|
|
Apr 01
2023
|
Mahesh Krishnan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,199
+50.0%
|
-
|